How do pharmaceutical companies identify adverse events of their drug
product on the market? (Please, answer with certain detail in the
METHODOLOGY used to identify them. Please, also cite the main
information RESOURCES used for this goal).

---

Clarification of Question by tom136-ga on 16 Mar 2003 15:55 PST

I am referring here to POST-MARKETING SURVELLIANCE of drug products. I
would like specifically to know the method that pharmaceutical
companies are using to monitor their respective products. AND MORE
SPECIFICALLY, HOW THEY MAKE RESEARCH IN LITERATURE DATABASES(ie.
Medline, Embase, etc.) for adverse events of the drug products they
market.

---

Clarification of Question by tom136-ga on 16 Mar 2003 15:57 PST

Note: I have posted another similar question, in order to allow
different researches to answer it, and to get differents approaches to
the same subject. I have also posted questions about different aspects
of pharmacovigilance. Please, be specific to the core of the
corresponding question. Thank you!